PMC:7534795 / 115485-115791 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T98","span":{"begin":172,"end":187},"obj":"Body_part"}],"attributes":[{"id":"A98","pred":"fma_id","subj":"T98","obj":"http://purl.org/sig/ont/fma/fma49893"}],"text":"However, despite statin monotherapy, many patients with dyslipidemia still suffer from persistently elevated triglyceride levels which may continue to be a risk factor for coronary artery disease, cardiac events and more severe COVID-19 infection outcomes (Ballantyne et al., 2012; Davidson, et al., 2007)."}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T158","span":{"begin":172,"end":187},"obj":"Body_part"},{"id":"T159","span":{"begin":181,"end":187},"obj":"Body_part"}],"attributes":[{"id":"A158","pred":"uberon_id","subj":"T158","obj":"http://purl.obolibrary.org/obo/UBERON_0001621"},{"id":"A159","pred":"uberon_id","subj":"T159","obj":"http://purl.obolibrary.org/obo/UBERON_0001637"}],"text":"However, despite statin monotherapy, many patients with dyslipidemia still suffer from persistently elevated triglyceride levels which may continue to be a risk factor for coronary artery disease, cardiac events and more severe COVID-19 infection outcomes (Ballantyne et al., 2012; Davidson, et al., 2007)."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T647","span":{"begin":56,"end":68},"obj":"Disease"},{"id":"T648","span":{"begin":172,"end":195},"obj":"Disease"},{"id":"T649","span":{"begin":181,"end":195},"obj":"Disease"},{"id":"T650","span":{"begin":228,"end":236},"obj":"Disease"},{"id":"T651","span":{"begin":237,"end":246},"obj":"Disease"}],"attributes":[{"id":"A647","pred":"mondo_id","subj":"T647","obj":"http://purl.obolibrary.org/obo/MONDO_0002525"},{"id":"A648","pred":"mondo_id","subj":"T648","obj":"http://purl.obolibrary.org/obo/MONDO_0005010"},{"id":"A649","pred":"mondo_id","subj":"T649","obj":"http://purl.obolibrary.org/obo/MONDO_0000473"},{"id":"A650","pred":"mondo_id","subj":"T650","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A651","pred":"mondo_id","subj":"T651","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"However, despite statin monotherapy, many patients with dyslipidemia still suffer from persistently elevated triglyceride levels which may continue to be a risk factor for coronary artery disease, cardiac events and more severe COVID-19 infection outcomes (Ballantyne et al., 2012; Davidson, et al., 2007)."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T162","span":{"begin":154,"end":155},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T163","span":{"begin":181,"end":187},"obj":"http://purl.obolibrary.org/obo/UBERON_0001637"},{"id":"T164","span":{"begin":181,"end":187},"obj":"http://www.ebi.ac.uk/efo/EFO_0000814"}],"text":"However, despite statin monotherapy, many patients with dyslipidemia still suffer from persistently elevated triglyceride levels which may continue to be a risk factor for coronary artery disease, cardiac events and more severe COVID-19 infection outcomes (Ballantyne et al., 2012; Davidson, et al., 2007)."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T4285","span":{"begin":17,"end":23},"obj":"Chemical"},{"id":"T61043","span":{"begin":109,"end":121},"obj":"Chemical"}],"attributes":[{"id":"A57748","pred":"chebi_id","subj":"T4285","obj":"http://purl.obolibrary.org/obo/CHEBI_87631"},{"id":"A60158","pred":"chebi_id","subj":"T61043","obj":"http://purl.obolibrary.org/obo/CHEBI_17855"}],"text":"However, despite statin monotherapy, many patients with dyslipidemia still suffer from persistently elevated triglyceride levels which may continue to be a risk factor for coronary artery disease, cardiac events and more severe COVID-19 infection outcomes (Ballantyne et al., 2012; Davidson, et al., 2007)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T705","span":{"begin":0,"end":306},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"However, despite statin monotherapy, many patients with dyslipidemia still suffer from persistently elevated triglyceride levels which may continue to be a risk factor for coronary artery disease, cardiac events and more severe COVID-19 infection outcomes (Ballantyne et al., 2012; Davidson, et al., 2007)."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T260","span":{"begin":56,"end":68},"obj":"Phenotype"}],"attributes":[{"id":"A260","pred":"hp_id","subj":"T260","obj":"http://purl.obolibrary.org/obo/HP_0003119"}],"text":"However, despite statin monotherapy, many patients with dyslipidemia still suffer from persistently elevated triglyceride levels which may continue to be a risk factor for coronary artery disease, cardiac events and more severe COVID-19 infection outcomes (Ballantyne et al., 2012; Davidson, et al., 2007)."}

{"project":"2_test","denotations":[{"id":"33031856-22819432-84039158","span":{"begin":276,"end":280},"obj":"22819432"},{"id":"33031856-17825687-84039159","span":{"begin":300,"end":304},"obj":"17825687"}],"text":"However, despite statin monotherapy, many patients with dyslipidemia still suffer from persistently elevated triglyceride levels which may continue to be a risk factor for coronary artery disease, cardiac events and more severe COVID-19 infection outcomes (Ballantyne et al., 2012; Davidson, et al., 2007)."}

{"project":"LitCovid-PubTator","denotations":[{"id":"3306","span":{"begin":42,"end":50},"obj":"Species"},{"id":"3312","span":{"begin":109,"end":121},"obj":"Chemical"},{"id":"3323","span":{"begin":56,"end":68},"obj":"Disease"},{"id":"3324","span":{"begin":172,"end":195},"obj":"Disease"},{"id":"3325","span":{"begin":228,"end":236},"obj":"Disease"},{"id":"3326","span":{"begin":237,"end":246},"obj":"Disease"}],"attributes":[{"id":"A3306","pred":"tao:has_database_id","subj":"3306","obj":"Tax:9606"},{"id":"A3312","pred":"tao:has_database_id","subj":"3312","obj":"MESH:D014280"},{"id":"A3323","pred":"tao:has_database_id","subj":"3323","obj":"MESH:D050171"},{"id":"A3324","pred":"tao:has_database_id","subj":"3324","obj":"MESH:D003324"},{"id":"A3325","pred":"tao:has_database_id","subj":"3325","obj":"MESH:C000657245"},{"id":"A3326","pred":"tao:has_database_id","subj":"3326","obj":"MESH:D007239"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"However, despite statin monotherapy, many patients with dyslipidemia still suffer from persistently elevated triglyceride levels which may continue to be a risk factor for coronary artery disease, cardiac events and more severe COVID-19 infection outcomes (Ballantyne et al., 2012; Davidson, et al., 2007)."}